Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
6.65
+0.95 (16.67%)
Nov 18, 2026, 4:00 PM EST - Market closed
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $15.2 million as of November 18, 2026. It is the 38,481st most valuable company in the world and the 5,267th biggest in the United States. Its market cap has decreased by 10.22% in one year.
Market Cap
15.20M
Enterprise Value
9.45M
1-Year Change
-10.22%
Global Rank
Country Rank
#5,267 United States
Category
ChartMarket Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $15.20M, a decrease of -94.79%. That is a compound annual growth rate of -23.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 15.20M | 14.85% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Marker Therapeutics | 13.95M |
| Quantum BioPharma | 13.93M |
| Actuate Therapeutics | 13.84M |
| Passage Bio | 13.58M |
| Tvardi Therapeutics | 13.47M |
| Allarity Therapeutics | 13.38M |
| Fractyl Health | 12.81M |
| aTyr Pharma | 12.72M |